28.07.2014 Views

Annual Review 2012 - Luxottica

Annual Review 2012 - Luxottica

Annual Review 2012 - Luxottica

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

110 |<br />

ANNUAL REPORT <strong>2012</strong><br />

market. If the market for a financial asset is not active (or if it refers to non-listed securities),<br />

the Group defines the fair value by utilizing valuation techniques. These techniques include<br />

using recent arms-length market transactions between knowledgeable willing parties, if<br />

available, reference to the current fair value of another instrument that is substantially the<br />

same, discounted cash flows analysis, and pricing models based on observable market<br />

inputs, which are consistent with the instruments under valuation.<br />

The valuation techniques are primarily based on observable market data as opposed to<br />

internal sources of information.<br />

At each reporting date, the Group assesses whether there is objective evidence that a<br />

financial asset is impaired. In the case of investments classified as financial assets held<br />

for sale, a prolonged or significant decline in the fair value of the investment below its<br />

cost is also considered an indicator that the asset is impaired. If any such evidence exists<br />

for an available-for-sale financial asset, the cumulative loss, measured as the difference<br />

between the cost of acquisition and the current fair value, net any impairment loss<br />

previously recognized in the consolidated statement of income, is removed from equity<br />

and recognized in the consolidated statement of income.<br />

Any impairment loss recognized on an investment classified as an available-for-sale<br />

financial asset is not reversed.<br />

Derivative financial instruments<br />

Derivative financial instruments are accounted for in accordance with IAS 39 - Financial<br />

Instruments: Recognition and Measurement.<br />

At the date the derivative contract is entered into, derivative instruments are accounted for<br />

at their fair value and, if they are not designated as hedging instruments, any changes in<br />

fair value after initial recognition are recognized as components of net income for the year.<br />

If, on the other hand, derivative instruments meet the requirements for being classified as<br />

hedging instruments, any subsequent changes in fair value are recognized according to<br />

the following criteria, as illustrated below.<br />

The Group designates certain derivatives as instruments for hedging specific risks<br />

associated with highly probable transactions (cash flow hedges).<br />

For each derivative financial instrument designated as a hedging instrument, the Group<br />

documents the relationship between the hedging instrument and the hedged item, as well<br />

as the risk management objectives, the hedging strategy and the methodology to measure<br />

the hedging effectiveness. The hedging effectiveness of the instruments is assessed both<br />

at the hedge inception date and on an ongoing basis. A hedging instrument is considered<br />

highly effective when both at the inception date and during the life of the instrument, any<br />

changes in fair value of the derivative instrument offset the changes in fair value or cash<br />

flows attributable to the hedged items.<br />

If the derivative instruments are eligible for hedge accounting, the following accounting<br />

criteria are applicable:

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!